TNFα gene polymorphism in steroid resistant nephrotic syndrome

[1]  R. Kumar,et al.  IL-4, IL-10 and TNF-α Polymorphisms in Idiopathic Membranous Nephropathy (IMN) , 2015 .

[2]  H. Madani,et al.  Association of cytokine genes polymorphisms and the response to corticosteroid therapy in children with idiopathic nephrotic syndrome: A pilot study in Egypt , 2014 .

[3]  G. Agarwal,et al.  Cytokine Gene Polymorphism in Idiopathic Nephrotic Syndrome Children , 2011, Indian Journal of Clinical Biochemistry.

[4]  L. Zakraoui,et al.  Tumor necrosis factor gene polymorphisms and susceptibility to rheumatoid arthritis in regional Tunisian population , 2011 .

[5]  D. English,et al.  Comprehensive analysis of the cytokine-rich chromosome 5q31.1 region suggests a role for IL-4 gene variants in prostate cancer risk. , 2010, Carcinogenesis.

[6]  G. Chernin,et al.  Plasmapheresis-induced clinical improvement in a patient with steroid-resistant nephrotic syndrome due to podocin (NPHS2) gene mutation. , 2010, Acta medica.

[7]  K. Mandal,et al.  Does cytokine gene polymorphism affect steroid responses in idiopathic nephrotic syndrome? , 2008, Indian journal of medical sciences.

[8]  M. Rizk,et al.  Serum interleukins and urinary microglobulin in children with idiopathic nephrotic syndrome. , 2005, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[9]  K. Pfeffer,et al.  The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games , 2005, Immunology.

[10]  C. Pusey,et al.  Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis. , 2005, Kidney international.

[11]  K. Choi,et al.  Association of IL-1β, IL-1ra, and TNF-α gene polymorphisms in childhood nephrotic syndrome , 2004, Pediatric Nephrology.

[12]  C. Heng,et al.  Childhood nephrotic syndrome in relapse is associated with down‐regulation of monocyte CD14 expression and lipopolysaccharide‐induced tumour necrosis factor‐α production , 2003, Clinical and experimental immunology.

[13]  B. Dijkmans,et al.  Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. , 2002, Rheumatology.

[14]  A. Thompson,et al.  Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity , 2002, Journal of Neuroimmunology.

[15]  B. Hoppe,et al.  Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. , 2002, Clinical science.

[16]  J. Skepper,et al.  Expression of Tumor Necrosis Factor Receptors in Normal Kidney and Rejecting Renal Transplants , 2001, Laboratory Investigation.

[17]  C. Janeway,et al.  T Cell-Mediated Immunity , 2001 .

[18]  Terlikowski Sj.  Tumour necrosis factor and cancer treatment: a historical review and perspectives. , 2001 .

[19]  S. Terlikowski.  Tumour necrosis factor and cancer treatment: a historical review and perspectives. , 2001, Roczniki Akademii Medycznej w Bialymstoku.

[20]  D. Zurakowski,et al.  Increased nuclear factor-kappaB and angiotensinogen gene expression in posttransplant recurrent focal segmental glomerulosclerosis. , 2000, Transplantation.

[21]  J. Weening,et al.  Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. , 2000, Journal of the American Society of Nephrology : JASN.

[22]  A. Tejani,et al.  Predictive Value of Repeat Renal Biopsies in Children with Nephrotic Syndrome , 2000, Nephron.

[23]  R. Ardaillou,et al.  Tumor necrosis factor in renal injury. , 1995, Mineral and electrolyte metabolism.

[24]  K. Matsumoto.  Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. , 1995, Nephron.

[25]  B. Myers,et al.  Elevated Levels of Tumor Necrosis Factor-α in the Nephrotic Syndrome in Humans , 1993 .

[26]  P. Lustenberger,et al.  An improved pyrogallol red-molybdate method for determining total urinary protein. , 1989, Clinical chemistry.